Location History:
- Lausanne, CH (2002 - 2003)
- Epalinges, CH (1998 - 2010)
Company Filing History:
Years Active: 1998-2010
Title: The Innovative Contributions of Pedro Romero
Introduction
Pedro Romero is a prominent inventor based in Epalinges, Switzerland. He has made significant contributions to the field of cancer research, particularly in the development of peptides that interact with HLA molecules. With a total of 11 patents to his name, Romero's work is at the forefront of immunotherapy advancements.
Latest Patents
Among his latest patents, Romero has developed isolated nona- and decapeptides that bind to HLA molecules, which are crucial for inducing the proliferation of cytolytic T cells. This method has the potential to enhance immune responses against cancer cells. Additionally, he has patented isolated nucleic acid molecules that encode peptides binding to HLA molecules, specifically those defined by an HLA-A2 binding motif. These nucleic acid molecules are accompanied by expression vectors that facilitate their use in therapeutic applications.
Career Highlights
Pedro Romero is affiliated with the Ludwig Institute for Cancer Research Limited, where he conducts groundbreaking research. His work has not only advanced scientific understanding but also paved the way for new treatment options in oncology. His innovative approach to peptide design and application has garnered attention in the scientific community.
Collaborations
Romero collaborates with esteemed colleagues, including Danila Valmori and Jean-Charles Cerottini. These partnerships enhance the research efforts and contribute to the development of effective cancer therapies.
Conclusion
Pedro Romero's contributions to cancer research through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in immunotherapy and offers hope for improved cancer treatments.